Neurotron, Incorporated Innovative Medical Technology Established 1981 |
||
Neurometer® Clinical Oncology Applications |
|
---|
Oncologists prescribe sNCT/CPT studies to assess the polyneuropathy of cancer and the neurotoxic side-effects of chemotherapeutic agents to assist in developing and modifying treatment plans/goals. A clinical presentation of sensory impairment which requires an objective evaluation for polyneuropathy with testing generally conducted at the great toe test site and a cephalic test site, bilaterally. See the web page with related publications cited, Selected Neurometer® CPT Research Publications Grouped by Topic and Specialty.
|
The entire contents of this web site are Copyright 1996-2010, Neurotron, Incorporated
Est. 1981, Baltimore, MD, USA. All rights reserved, worldwide
rev 10/16/09 |